Department of Pediatrics, University of California, Davis School of Medicine, Sacramento.
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City.
JAMA Pediatr. 2022 Feb 1;176(2):169-175. doi: 10.1001/jamapediatrics.2021.5038.
Diabetic kidney disease is among the most important causes of end-stage kidney disease worldwide. Risk factors for diabetic kidney disease remain incompletely defined. Recent studies document a high frequency of acute kidney injury (AKI) during diabetic ketoacidosis (DKA) in children, raising the question of whether these AKI episodes might contribute to future risk of diabetic kidney disease.
To determine whether episodes of AKI occurring during DKA in children are associated with increased risk of development of microalbuminuria.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective review of medical records included children with type 1 diabetes with 1 or more urine albumin levels measured during routine diabetes care from 2 university-affiliated urban tertiary children's hospitals in the United States from January 2006 to December 2019. Age at diagnosis of diabetes, hemoglobin A1c levels, episodes of DKA, pH and creatinine levels during DKA, and urine albumin and creatinine measurements were analyzed. Cox proportional hazards regression models were used to identify variables affecting the hazard rate for microalbuminuria development. Analyses began January 2021 and ended May 2021.
Episodes of DKA and episodes of AKI occurring during DKA.
AKI occurrence and AKI stage were determined from serum creatinine measurements during DKA using Kidney Disease: Improving Global Outcomes criteria. Microalbuminuria was defined as urine albumin-to-creatinine ratio of 30 mg/g or more or excretion of 30 mg or more of albumin in 24 hours.
Of 2345 children, the mean (SD) age at diagnosis was 9.4 (4.4) years. One or more episodes of DKA occurred in 963 children (41%), and AKI occurred during DKA in 560 episodes (47%). In multivariable models adjusting for the associations of age at diagnosis and mean hemoglobin A1c level since diagnosis, each episode of AKI during DKA was associated with a hazard ratio of 1.56 (95% CI, 1.3-1.87) for development of microalbuminuria. Four or more episodes increased the hazard rate by more than 5-fold. DKA episodes without AKI did not significantly increase the hazard rate for microalbuminuria development after adjusting for other covariates.
These data demonstrate that episodes of AKI occurring during DKA in children with type 1 diabetes are significantly associated with risk of developing microalbuminuria. Greater efforts are necessary to reduce the frequency of DKA.
糖尿病肾病是全球最重要的终末期肾病病因之一。糖尿病肾病的风险因素仍不完全明确。最近的研究记录了儿童糖尿病酮症酸中毒(DKA)期间急性肾损伤(AKI)的高频率,这引发了一个问题,即这些 AKI 发作是否会增加未来发生糖尿病肾病的风险。
确定儿童 DKA 期间发生的 AKI 发作是否与微量白蛋白尿风险增加相关。
设计、地点和参与者:这是一项在美国 2 所大学附属城市三级儿童医院的常规糖尿病护理中对 1 型糖尿病儿童进行的回顾性病历研究,从 2006 年 1 月至 2019 年 12 月共纳入 1 次或多次测量尿白蛋白水平的儿童。分析糖尿病诊断时的年龄、血红蛋白 A1c 水平、DKA 发作次数、DKA 期间的 pH 值和肌酐水平以及尿白蛋白和肌酐测量值。使用 Cox 比例风险回归模型确定影响微量白蛋白尿发展风险率的变量。分析于 2021 年 1 月开始,2021 年 5 月结束。
DKA 发作和 DKA 期间发生的 AKI 发作。
根据肾脏疾病:改善全球结局标准,通过 DKA 期间的血清肌酐测量确定 AKI 的发生和 AKI 分期。微量白蛋白尿定义为尿白蛋白/肌酐比值≥30mg/g 或 24 小时内排出 30mg 或更多白蛋白。
在 2345 名儿童中,诊断时的平均(SD)年龄为 9.4(4.4)岁。963 名(41%)儿童发生 1 次或多次 DKA 发作,560 次(47%)DKA 期间发生 AKI。在调整诊断时年龄和诊断后平均血红蛋白 A1c 水平关联的多变量模型中,DKA 期间每次 AKI 发作与微量白蛋白尿发展的风险比为 1.56(95%CI,1.3-1.87)。发作 4 次或更多次会使风险率增加 5 倍以上。在调整其他协变量后,无 AKI 的 DKA 发作与微量白蛋白尿发展的风险率无显著相关性。
这些数据表明,1 型糖尿病儿童 DKA 期间发生的 AKI 与发生微量白蛋白尿的风险显著相关。需要进一步努力降低 DKA 的发生频率。